PubRank

N Stefan

Author PubWeight™ 50.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007 3.34
2 Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008 2.57
3 Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 2007 2.16
4 Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes 2008 1.96
5 High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 2008 1.53
6 The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia 2008 1.53
7 The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 2010 1.45
8 A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 2009 1.27
9 Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 2007 1.23
10 Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Diabetologia 2000 1.19
11 Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2010 1.14
12 Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study. MAGMA 2005 1.11
13 Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia 2012 1.05
14 Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes 2001 1.02
15 A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest 2000 1.01
16 Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab 2005 0.99
17 Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 2002 0.97
18 mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int J Obes (Lond) 2009 0.96
19 Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 2008 0.96
20 Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 2006 0.95
21 The risk allele load accelerates the age-dependent decline in beta cell function. Diabetologia 2009 0.94
22 The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes 2001 0.92
23 Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes. Exp Clin Endocrinol Diabetes 2011 0.92
24 High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 2011 0.92
25 PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors. Diabetologia 2005 0.89
26 Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 2011 0.89
27 Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites. Diabetologia 2007 0.89
28 Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content. Int J Obes (Lond) 2011 0.88
29 The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. Exp Clin Endocrinol Diabetes 2010 0.85
30 Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia. Diabetes Obes Metab 2012 0.85
31 Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. J Clin Endocrinol Metab 2001 0.84
32 Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001 0.84
33 The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention. Diabetologia 2009 0.83
34 Insulin resistant phenotype of polycystic ovary syndrome does not seem to be caused by variation in FTO. Horm Metab Res 2012 0.82
35 Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2005 0.82
36 Reducing visceral adipose tissue mass is essential for improving endothelial function in type 2 diabetes prone individuals. Atherosclerosis 2010 0.81
37 The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition. Exp Clin Endocrinol Diabetes 2008 0.81
38 Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. Horm Metab Res 2007 0.81
39 Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. Exp Clin Endocrinol Diabetes 2006 0.81
40 Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy White population. Diabet Med 2007 0.80
41 Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. Diabetologia 2011 0.80
42 The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function. Diabetologia 2004 0.79
43 AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study. Exp Clin Endocrinol Diabetes 2009 0.78
44 Genetic variability of procolipase associates with altered insulin secretion in non-diabetic Caucasians. Exp Clin Endocrinol Diabetes 2008 0.78
45 Selective association of plasma non-esterified fatty acid species with circulating interleukin-8 concentrations in humans. Exp Clin Endocrinol Diabetes 2008 0.76
46 The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention. Diabetologia 2007 0.75
47 Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans. Acta Diabetol 2013 0.75
48 A 60 minute hyperglycemic clamp is sufficient to assess both phases of insulin secretion. Horm Metab Res 2000 0.75
49 [Gene-environment interactions in the pathogenesis and prevention of type 2 diabetes mellitus]. Internist (Berl) 2007 0.75
50 [Liver volume, intrahepatic fat and body weight in the course of a lifestyle interventional study: Analysis with quantitative MR-based methods]. Radiologe 2015 0.75
51 Animal Trichinella infection in Romania: geographical heterogeneity for the last 8 years. Vet Parasitol 2008 0.75
52 A novel functional polymorphism (-336A/G) in the promoter of the partitioning-defective protein-6alpha gene is associated with increased glucose tolerance and lower concentrations of serum non-esterified fatty acids. Diabetologia 2005 0.75